Name: BIOAGE LABS INC (BIOA) Stock
Brand: BIOAGE LABS INC
Rating: 5.5 (3 reviews)

BIOA Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Chartmill

BioAge Labs Inc (NASDAQ:BIOA) Reports Q3 2025 Earnings with Significant Revenue Beat

18 days ago - By: Chartmill - Mentions: SLE AMBI ITGR LXEH ...

Here are the top movers in Thursday's session.

4 days ago - By: BioAge Labs, Inc.

BioAge Labs to Present at Jefferies Global Healthcare Conference in London

4 days ago - By: BioAge Labs, Inc.

BioAge Labs to Present at Jefferies Global Healthcare Conference in London

4 days ago - By: BioAge Labs, Inc.

BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates

4 days ago - By: BioAge Labs, Inc.

BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates

6 days ago - By: The Motley Fool - Mentions: NVO LLY C

Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy

13 days ago - By: The Motley Fool - Mentions: LLY C

Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026?

19 days ago - By: Benzinga - Mentions: MOH ITGR ARMP RVPH ...

12 Health Care Stocks Moving In Thursday's Intraday Session

19 days ago - By: Chartmill - Mentions: CLB SLE AMBI ITGR ...

Which stocks are moving on Thursday?

19 days ago - By: Chartmill - Mentions: CLB SSL AMBI ITGR ...

These stocks are gapping in today's session

19 days ago - By: Chartmill - Mentions: SLE MOH BYND ARMP ...

Wondering what's happening in today's pre-market session?

19 days ago - By: Benzinga - Mentions: CNC MOH IBIO MEDP ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

a month ago - By: Bragar Eagel & Squire

BIOAGE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

2 months ago - By: HitGen Inc.

HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor

3 months ago - By: BioAge Labs, Inc.

BioAge Labs to Present at Upcoming Investor Conferences

3 months ago - By: BioAge Labs, Inc.

BioAge Labs to Present at Upcoming Investor Conferences

3 months ago - By: BioAge Labs, Inc.

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

3 months ago - By: BioAge Labs, Inc.

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

3 months ago - By: BioAge Labs, Inc.

BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates

3 months ago - By: BioAge Labs, Inc.

BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates

3 months ago - By: Yahoo Finance

BioAge (BIOA) to Analyze Over 17,000 Biobank Samples for Drug Discovery

4 months ago - By: Bragar Eagel & Squire

BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

5 months ago - By: BioAge Labs, Inc.

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

5 months ago - By: BioAge Labs, Inc.

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

5 months ago - By: BioAge Labs, Inc.

BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank

5 months ago - By: BioAge Labs, Inc.

BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank

5 months ago - By: BioAge Labs, Inc.

BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates

5 months ago - By: BioAge Labs, Inc.